Boston, MA 05/19/2014 (wallstreetpr) – Morgan Stanley Income Securities Inc. (NYSE:ICB) will pay $0.0525 per share in monthly income dividend on May 30. The payment will capture investors of record as of May 23. Shares of the closed-end management investment company traded down 0.06 percent for the whole of last week. The shares are up 6.9 percent since the beginning of 2014. The company seeks to provide investors with high-level and income from its prudent investment. Morgan Stanley Income Securities Inc. (NYSE:ICB) saw its share up at $18.32 in the past 52-weeks.
The injectable drugs company Hospira, Inc. (NYSE:HSP) looks forward to significant revenue growth in the current quarter and possibly the whole of 2014. The company has landed a product sales opportunity in Canada following the suspension of the license of a player in the market. The company has not only increased supply of a chemotherapy drug in the Canadian market, but also said it is capable of meeting the big demand, therefore, allaying shortage fears. Biolyse Pharma Corp stopped production of paclitaxel after inspectors raised issues over its manufacturing practice and a host of other concerns. However, the company will be back in the market after it has addressed the issues raised. In the meantime, Hospira has moved to fill the gap and increase revenue. According to Hospira, Inc. (NYSE:HSP) spokesperson Daniel Rosenberg, the company quickly put its production and supply chain in order to step in to address the shortage of paclitaxel after learning of the license suspension issue. Therefore, the company is well-placed to make the money and also help patients to access their treatment needs.
Speculations are widespread that lithium battery separator Polypore International, Inc. (NYSE:PPO) may be in the contact list of the fast-rising all-electric car manufacturer Tesla Motors Inc (NASDAQ:TSLA). PPO provides battery pack separation solution, and it enjoys a good reputation in the industry. In addition to the positive reputation, the company’s low-cost products are also seen as consideration in the rumored potential deal. Tesla seeks to set up a mega factory to manufacture lithium-ion batteries for use in its Model S car and the upcoming car models.